(Q49037483)

18 February 2018

title

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. (English)

1 reference

18 February 2018

1 reference

1 reference

7

Jeffrey H Kordower

1 reference

18 February 2018

2

Ali Keshavarzian

1 reference

18 February 2018

author name string

Kathleen M Shannon

1

1 reference

18 February 2018

Ece Mutlu

3

1 reference

18 February 2018

Hemraj B Dodiya

4

1 reference

18 February 2018

Delia Daian

5

1 reference

18 February 2018

Jean A Jaglin

6

1 reference

18 February 2018

language of work or name

English

0 references

publication date

15 July 2011

1 reference

18 February 2018

published in

Movement Disorders

1 reference

18 February 2018

volume

27

1 reference

18 February 2018

issue

6

1 reference

18 February 2018

page(s)

709-715

1 reference

18 February 2018

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

cites work

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.

21 January 2018

1 reference

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

21 January 2018

1 reference

Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

Can we image premotor Parkinson disease?

21 January 2018

1 reference

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

21 January 2018

1 reference

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

21 January 2018

1 reference

Frequency of bowel movements and the future risk of Parkinson's disease

21 January 2018

1 reference

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

21 January 2018

1 reference

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

21 January 2018

1 reference

Cuprolinic blue (quinolinic phthalocyanine) counterstaining of enteric neurons for peroxidase immunocytochemistry.

21 January 2018

1 reference

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders

21 January 2018

1 reference

Life style risks of Parkinson's disease: association between decreased water intake and constipation.

21 January 2018

1 reference

Constipation in Parkinson's disease: objective assessment and response to psyllium

21 January 2018

1 reference

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

21 January 2018

1 reference

Excessive daytime sleepiness and subsequent development of Parkinson disease

21 January 2018

1 reference

Clinical prediction of Parkinson's disease: planning for the age of neuroprotection.

21 January 2018

1 reference

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23838

1 reference

18 February 2018

1 reference

18 February 2018